Evidence map›Paper›PMID 34049899›Full record

SynthesisBMJ open2021

Meta-analysis of the prognostic value of pretreatment serum ferritin in hepatobiliary and pancreas (HBP) cancers.

Shuwen Lin, Yinghua Fang, Ye Lin, Zhikang Mo, Xiaocheng Hong, Zhixiang Jian, Chenggang Ji

Open access · goldAbstract readMeta-Analysis
In one paragraph

Synthesis in BMJ open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Shuwen Lin *General Surgery, Binhaiwan Central Hospital of Dongguan, Dongguan, China.ORCID 0000-0002-0621-5067
Yinghua Fang *Pain, Binhaiwan Central Hospital of Dongguan, Dongguan, China.
Ye Lin *General Surgery, Guangdong Provincial People's Hospital, Guangzhou, China.
Zhikang MoGeneral Surgery, Binhaiwan Central Hospital of Dongguan, Dongguan, China.
Xiaocheng HongGeneral Surgery, Binhaiwan Central Hospital of Dongguan, Dongguan, China.
Zhixiang JianGeneral Surgery, Guangdong Provincial People's Hospital, Guangzhou, China.
Chenggang JiGeneral Surgery, Binhaiwan Central Hospital of Dongguan, Dongguan, China jcg_999@163.com.
Dongguan People’s Hospital · CNGuangdong Provincial People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectivesStudies have shown that serum ferritin (SF) has unfavourable prognostic value in hepatobiliary and pancreas (HBP) cancers. This meta-analysis aimed to comprehensively assess the prognostic role of pretreatment SF in patients with HBP cancers.

methodsEligible studies published before January 2020 were obtained through a comprehensive search in the PubMed, Web of Science, Cochrane Library and EMBASE databases. Pooled HRs and 95% CIs were then employed as effect sizes.

resultsSeven studies comprising 1244 patients were pooled. Elevated pretreatment SF was associated with worse overall survival (OS) (HR 1.60, 95% CI 1.36 to 1.88, p<0.001) and recurrence-free survival/progression-free survival/time to recurrence (HR 1.70, 95% CI 1.15 to 2.52, p=0.008). Significant prognostic value of elevated pretreatment SF on OS was detected in the subgroups regardless of the cancer type, race, SF cut-off value, tumour-node-metastasis stage and Newcastle-Ottawa Scale score.

conclusionElevated pretreatment SF was associated with worse survival outcome of patients with HBP cancers. As such, it may serve as a novel prognostic biomarker for HBP cancers.

Indexed as

Pancreatic NeoplasmsFerritinsHumansPancreasPrognosisFerritinshepatobiliary surgeryhepatobiliary tumoursmolecular biologypancreatic diseasepancreatic surgery

Identifiers

PMID34049899
PMCPMC8166605
OpenAlexW3164573762

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.